Meningococcal disease in Ireland since the introduction of meningococcal serogroup C conjugate vaccination

M Fitzgerald; J O’Donnell; D O'Flanagan; M Cafferkey; K Murphy

doi:10.2807/esw.08.05.02376-en

Articles Open Access

Like 0

This item has no PDF Download

Meningococcal disease in Ireland since the introduction of meningococcal serogroup C conjugate vaccination
M Fitzgerald , J O’Donnell , D O'Flanagan , M Cafferkey , K Murphy
View Citation Hide Citation

Citation style for this article: Fitzgerald M, O’Donnell J, O'Flanagan D, Cafferkey M, Murphy K. Meningococcal disease in Ireland since the introduction of meningococcal serogroup C conjugate vaccination. Euro Surveill. 2004;8(5):pii=2376. https://doi.org/10.2807/esw.08.05.02376-en

Abstract

Eleven months after its launch in the United Kingdom (1), the meningococcal serogroup C conjugate vaccine (MenC vaccine) was introduced in Ireland in October 2000.